Skip to main content
. 2020 Dec 11;73(1):126–143. doi: 10.1002/hep.31523

Table 1.

Patient Demographics and Baseline Characteristics

Parameters Patients (n = 176)
Age (years) 51.2 (10.6)
Weight (kg) 100.2 (21.5)
BMI (kg/m2) 36.4 (7.1)
Sex
Female 121 (69%)
Male 55 (31%)
Race
Asian 3 (2%)
Black 2 (1%)
White 166 (94%)
Other 5 (3%)
Ethnicity
Hispanic/Latino 82 (47%)
Non‐Hispanic/Latino 94 (53%)
Type 2 diabetes
Yes 87 (49%)
No 89 (51%)
Histology
Fibrosis stage
1 62 (35%)
2 56 (32%)
3 56 (32%)
4 2 (1%)
Total NAS score 5.3 (1.2)
Ballooning
0 (none) 6 (3%)
1 (few ballooned cells) 85 (48%)
2 (many ballooned cells) 84 (48%)
Steatosis
0 (<5%) 0
1 (5%‐33%) 40 (23%)
2 (34%‐66%) 76 (43%)
3 (>66%) 59 (34%)
Inflammation
0 (none) 0
1 (<2) 59 (34%)
2 (2‐4) 100 (57%)
3 (>4) 16 (9%)
LFC by MRI‐PDFF
LFC (%) 18.6 (6.8)

Note: Values are presented as mean (SD) or n (%). Percentages may not total 100 because of rounding.

Abbreviations: BMI, body mass index; NAS, nonalcoholic fatty liver disease activity score.